Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tahani Alwidyan"'
Publikováno v:
Alwidyan, T, McCorry, N K & Parsons, C 2023, ' Healthcare professionals’ perspectives of deprescribing in older patients at the end of life in hospice care: a qualitative study using the Theoretical Domains Framework ', International Journal of Pharmacy Practice . https://doi.org/10.1093/ijpp/riad005
Objectives This study aimed to investigate healthcare professionals’ barriers to and enablers of deprescribing in older hospice patients at the end of life and prioritise relevant theoretical domains for behaviour change to be incorporated into fut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13537fe0dd35aee35d4e231e51c0fee9
https://doi.org/10.1093/ijpp/riad005
https://doi.org/10.1093/ijpp/riad005
Autor:
Bara'a Shawaqfeh, Marianna Drakopoulou, Matthew Quinn, Andrea Iribarren López, Emma Burke, Jacob George, Dimos Mastrogiannis, Sofiane Boudaoud, Lucy Faulkner, Mariapaola Nastri, Tahani Alwidyan
Publikováno v:
European Geriatric Medicine. 12:1-387
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1e851c213c6868c05523e2441b89b99
https://doi.org/10.1007/s41999-021-00585-2
https://doi.org/10.1007/s41999-021-00585-2
Autor:
Julie Mason, Matt Williams, Amie Bain, Sarah Willis, Christopher Curtis, Anthony Cox, Abdel Rahman Medani, Matthew Jones, Jennifer Scott, Asma Yahyouche, Abbie Jordan, Alan Jones, Lucy Faulkner, Tahani Alwidyan, Sallianne Kavanagh
Publikováno v:
International Journal of Pharmacy Practice. 28:44-87
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ee09dacd98186bf79429f34a7baf948
https://doi.org/10.1111/ijpp.12607
https://doi.org/10.1111/ijpp.12607
Autor:
Lubna Swellmeen, Rand Shahin, Yaser Al-Qarar’h, Tahani Alwidyan, Iman Mansi, Nabil N. Al-Hashimi, O. H. Shaheen
Publikováno v:
Journal of molecular graphicsmodelling. 80
Targeting tropomycin kinase A (TrkA) by small molecule inhibitors is considered as a promising strategy for treating several human cancers. To achieve this goal, a ligand based QSAR model was applied using the Discovery studio 4.5 (DS 4.5). Hence, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d31c6a1531d01c92b13ce70bb6d558f9
https://pubmed.ncbi.nlm.nih.gov/29454290
https://pubmed.ncbi.nlm.nih.gov/29454290